HighTide Therapeutics to Cooperate on Chronic Diseases, Longevity, Anti-Aging with SSY Group

MT Newswires Live

2024/12/19

HighTide Therapeutics' (HKG:2511) subsidiary entered into a strategic co-operation framework agreement with SSY Group's (HKG:2005) subsidiary Shijiazhuang No. 4 Pharmaceutical regarding possible cooperation the fields of metabolic chronic diseases, longevity and anti-aging, a Thursday Hong Kong bourse filing said.

Under the framework agreement, the parties will leverage their individual expertise and advantages for the research and development of solutions for metabolic chronic diseases, longevity, and anti-aging at a global level.

The parties will enter into specific cooperation agreements for formal cooperation.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492147255"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492147255\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492147255?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-19 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492147255","market":"us","top_or_hot":-1,"title":"HighTide Therapeutics to Cooperate on Chronic Diseases, Longevity, Anti-Aging with SSY Group","media":"MT Newswires Live","content":"<html><body><p> HighTide <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' (HKG:2511) subsidiary entered into a strategic co-operation framework agreement with SSY Group's (HKG:2005) subsidiary Shijiazhuang No. 4 Pharmaceutical regarding possible cooperation the fields of metabolic chronic diseases, longevity and anti-aging, a Thursday Hong Kong bourse filing said.</p><p>Under the framework agreement, the parties will leverage their individual expertise and advantages for the research and development of solutions for metabolic chronic diseases, longevity, and anti-aging at a global level.</p><p>The parties will enter into specific cooperation agreements for formal cooperation.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HighTide Therapeutics to Cooperate on Chronic Diseases, Longevity, Anti-Aging with SSY Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHighTide Therapeutics to Cooperate on Chronic Diseases, Longevity, Anti-Aging with SSY Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-19 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> HighTide <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' (HKG:2511) subsidiary entered into a strategic co-operation framework agreement with SSY Group's (HKG:2005) subsidiary Shijiazhuang No. 4 Pharmaceutical regarding possible cooperation the fields of metabolic chronic diseases, longevity and anti-aging, a Thursday Hong Kong bourse filing said.</p><p>Under the framework agreement, the parties will leverage their individual expertise and advantages for the research and development of solutions for metabolic chronic diseases, longevity, and anti-aging at a global level.</p><p>The parties will enter into specific cooperation agreements for formal cooperation.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02511","symbol_name":"君圣泰医药-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492147255","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492147255","pubTimestamp":1734603827,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"HighTide Therapeutics'  subsidiary entered into a strategic co-operation framework agreement with SSY Group's  subsidiary Shijiazhuang No. 4 Pharmaceutical regarding possible cooperation the fields of metabolic chronic diseases, longevity and anti-aging, a Thursday Hong Kong bourse filing said.Under the framework agreement, the parties will leverage their individual expertise and advantages for the research and development of solutions for metabolic chronic diseases, longevity, and anti-aging at a global level.The parties will enter into specific cooperation agreements for formal cooperation.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02511":"君圣泰医药-B","BK1161":"生物科技","LENZ":"Therapeutics","BK1191":"制药","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","BK4139":"生物科技","SSY":"Sunlink Health Systems Inc","02005":"石四药集团","BK4185":"保健护理机构"},"translate_title":"HighTide Therapeutics将与SSY集团在慢性病、长寿、抗衰老方面开展合作","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02511":0.9,"SSY":1,"LENZ":1,"02005":0.9},"content_text":"HighTide Therapeutics' (HKG:2511) subsidiary entered into a strategic co-operation framework agreement with SSY Group's (HKG:2005) subsidiary Shijiazhuang No. 4 Pharmaceutical regarding possible cooperation the fields of metabolic chronic diseases, longevity and anti-aging, a Thursday Hong Kong bourse filing said.Under the framework agreement, the parties will leverage their individual expertise and advantages for the research and development of solutions for metabolic chronic diseases, longevity, and anti-aging at a global level.The parties will enter into specific cooperation agreements for formal cooperation.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}